J Cancer 2024; 15(11):3427-3440. doi:10.7150/jca.95269 This issue Cite

Research Paper

Single-cell and spatial transcriptome sequencing uncover a platinum-resistant cluster overexpressed TACSTD2 in high-grade serous ovarian cancer

Xiaoyang Han1, Yan Gao1, Mei Jiang1, Zhefeng Li1, Jiahao Guo1, Yue Li1, Junjie Yi1, Lisha Hou1, Jin Cheng1, Lei Feng1, Yulan Jin2✉, Xiaoting Zhao1✉, Wentao Yue1✉

1. Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, China.
2. Department of Pathology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, China.

Citation:
Han X, Gao Y, Jiang M, Li Z, Guo J, Li Y, Yi J, Hou L, Cheng J, Feng L, Jin Y, Zhao X, Yue W. Single-cell and spatial transcriptome sequencing uncover a platinum-resistant cluster overexpressed TACSTD2 in high-grade serous ovarian cancer. J Cancer 2024; 15(11):3427-3440. doi:10.7150/jca.95269. https://www.jcancer.org/v15p3427.htm
Other styles

File import instruction

Abstract

Graphic abstract

Purpose: Platinum-based chemotherapy is effective but limited by resistance in high-grade serous ovarian cancer (HGSOC). Single-cell RNA sequencing (scRNA-seq) can reveal tumour cell heterogeneity and subclonal differentiation. We aimed to analyze resistance mechanisms and potential targets in HGSOC using scRNA-seq.

Methods: We performed 10× genomics scRNA-seq sequencing on tumour tissues from 3 platinum-sensitive and 3 platinum-resistant HGSOC patients. We analyzed cell subcluster communication networks and spatial distribution using cellchat. We performed RNA-seq analysis on TACSTD2, a representative resistance gene in the E0 subcluster, to explore its molecular mechanism.

Results: Epithelial cells, characterized by distinct chemotherapy resistance traits and highest gene copy number variations, revealed a specific cisplatin-resistant cluster (E0) associated with poor prognosis. E0 exhibited malignant features related to resistance, fostering growth through communication with fibroblasts and endothelial cells. Spatially, E0 promoted fibroblasts to protect tumour cells and impede immune cells infiltration. Furthermore, TACSTD2 was identified as a representative gene of the E0 subcluster, elucidating its role in platinum resistance through the Rap1/PI3K/AKT pathway.

Conclusions: Our study reveals a platinum-resistant epithelial cell subcluster E0 and its association with TACSTD2 in HGSOC, uncovers new insights and evidence for the platinum resistance mechanism, and provides new ideas and targets for the development of therapeutic strategies against TACSTD2+ epithelial cancer cells.

Keywords: ovarian cancer, platinum resistance, TACSTD2, prognosis, scRNA-seq


Citation styles

APA
Han, X., Gao, Y., Jiang, M., Li, Z., Guo, J., Li, Y., Yi, J., Hou, L., Cheng, J., Feng, L., Jin, Y., Zhao, X., Yue, W. (2024). Single-cell and spatial transcriptome sequencing uncover a platinum-resistant cluster overexpressed TACSTD2 in high-grade serous ovarian cancer. Journal of Cancer, 15(11), 3427-3440. https://doi.org/10.7150/jca.95269.

ACS
Han, X.; Gao, Y.; Jiang, M.; Li, Z.; Guo, J.; Li, Y.; Yi, J.; Hou, L.; Cheng, J.; Feng, L.; Jin, Y.; Zhao, X.; Yue, W. Single-cell and spatial transcriptome sequencing uncover a platinum-resistant cluster overexpressed TACSTD2 in high-grade serous ovarian cancer. J. Cancer 2024, 15 (11), 3427-3440. DOI: 10.7150/jca.95269.

NLM
Han X, Gao Y, Jiang M, Li Z, Guo J, Li Y, Yi J, Hou L, Cheng J, Feng L, Jin Y, Zhao X, Yue W. Single-cell and spatial transcriptome sequencing uncover a platinum-resistant cluster overexpressed TACSTD2 in high-grade serous ovarian cancer. J Cancer 2024; 15(11):3427-3440. doi:10.7150/jca.95269. https://www.jcancer.org/v15p3427.htm

CSE
Han X, Gao Y, Jiang M, Li Z, Guo J, Li Y, Yi J, Hou L, Cheng J, Feng L, Jin Y, Zhao X, Yue W. 2024. Single-cell and spatial transcriptome sequencing uncover a platinum-resistant cluster overexpressed TACSTD2 in high-grade serous ovarian cancer. J Cancer. 15(11):3427-3440.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image